TDCPP mimics thyroid hormones associated with the activation of integrin αvβ3 and ERK1/2

Jian Li1, Hedan Liu1, Na Li2

  • 1Engineering Research Center of Groundwater Pollution Control and Remediation, Ministry of Education, College of Water Sciences, Beijing Normal University, Beijing, 100875, China.

Chemosphere
|May 21, 2020
PubMed

Insights

Tri(1,3-dichloropropyl) phosphate (TDCPP) and its metabolite BDCPP mimic thyroid hormones, affecting cell growth and gene expression. They interact with integrin αvβ3, activating the ERK1/2 pathway, revealing new toxic mechanisms.

Area of Science:

  • Endocrinology
  • Toxicology
  • Cell Biology

Background:

  • Tri(1,3-dichloropropyl) phosphate (TDCPP) is a flame retardant with suspected thyroid-disrupting properties.
  • Limited knowledge exists regarding the specific toxic effects and mechanisms of TDCPP and its metabolite, bis(1,3-dichloro-2-propyl) phosphate (BDCPP).

Purpose of the Study:

  • To investigate the thyroid hormone-disrupting effects of TDCPP and BDCPP.
  • To elucidate the underlying molecular mechanisms of TDCPP and BDCPP toxicity in rat pituitary GH3 cells.

Main Methods:

  • Utilized rat pituitary GH3 cell lines.
  • Assessed cell proliferation and cell cycle progression.
  • Measured gene expression of c-fos and Tshβ via real-time PCR.
  • Investigated binding interactions with membrane thyroid hormone receptor (integrin αvβ3) using competition assays.
  • Performed molecular docking analysis.
  • Analyzed extracellular signal-regulated protein kinase (ERK1/2) pathway activation.

Main Results:

  • TDCPP and BDCPP promoted GH3 cell proliferation and modulated cell cycle progression.
  • Both compounds upregulated c-fos and downregulated Tshβ gene expression, mimicking thyroid hormone (TH) effects.
  • Significant competition for binding to integrin αvβ3 was observed, indicating strong binding.
  • Molecular docking confirmed high binding affinities for TDCPP and BDCPP to integrin αvβ3 at the RGD-binding site.
  • Evidence suggests TDCPP and BDCPP activate the ERK1/2 signaling pathway after binding to integrin αvβ3.

Conclusions:

  • TDCPP and BDCPP exhibit thyroid hormone-mimicking properties.
  • Their mechanism of action involves interaction with integrin αvβ3 and subsequent activation of the ERK1/2 pathway.
  • These findings provide novel insights into the cytotoxicity of TDCPP and BDCPP.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.2K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
4.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
17.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K